SMAD4 and colorectal carcinoma: Functional genetic alterations in the SMAD4 coding region occur in about 30% of colorectal cancer (CRC) patients and it includes loss of heterozygosity which is often followed by deletion of the other allele or intragenic inactivating mutation, which eventually leads to decreased expression level or total loss of SMAD4 protein 2.